Genes & biomarkers
ESR1 variants
ESR1 · estrogen receptor
ER-positive pathology and an ESR1 variant are different pieces of information.
Sources checked · Introductory guide
On this page
What does this result mean?
ESR1 encodes the estrogen receptor. ER positivity describes receptor protein; an ESR1 variant describes a DNA change. One result cannot substitute for the other.[1]
How does it connect to treatment?
In the US, elacestrant is used in selected postmenopausal women and adult men with ESR1-mutated, ER-positive, HER2-negative advanced breast cancer after endocrine progression. Check individual eligibility and local access.[2]
What should I check in my report?
Review the test date, exact ESR1 variant and previous endocrine drugs. ER positivity alone is not an ESR1 mutation result.
Questions for your care team
- Would ESR1 testing help before changing my current treatment?
- Which treatments or trials fit my cancer type, stage and previous treatment?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- NCI · Elacestrant Dihydrochloride (opens in a new tab)
- FDA · ORSERDU prescribing information (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.